Skip to main content
Log in

Serum levels of interleukin-1β and interleukin-6 in patients with chronic pancreatitis

  • Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

To investigate the role played by cytokines in chronic pancreatitis, we examined serum levels of interleukin-1β (IL-1β) and interleukin-6 (IL-6) by radioimmunoassay (RIA) and enzyme-linked immunosorbent assay (ELISA) in 33 patients with definitively diagnosed chronic pancreatitis. All the patients, who had received either no treatment or only digestive enzyme products for their chronic pancreatitis, had significantly elevated serum IL-1β levels (38.5±28.8pg/ml, mean ± SD), compared to normal controls (16.0±6.7pg/ml;P<0.01); however they showed no changes in serum IL-6 levels. Changes in IL-1β and IL-6 serum levels were not correlated with the etiological features of pancreatitis or with complications due to liver diseases. Serum IL-1β and IL-6 levels were also not correlated with the activity of any pancreatic enzymes in blood or urine. However, in the patients with chronic pancreatitis, serum IL-6 levels were correlated with C-reactive protein (CRP), whereas serum IL-1β levels were not correlated with CRP or with erythrocyte sedimentation rate. These results suggest that serum IL-1β is involved in the progression and reduction of chronic inflammation of the pancreas, and that the serum IL-1β level may be useful as a marker for chronic pancreastitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Creutzfeldt W, Schmidt H. Aetiology and pathogenesis of pancreatitis, Scand J Gastroenterol 1970;6(Suppl):47–62.

    CAS  Google Scholar 

  2. Steer ML. Etiology and pathophysiology of acute pancreatitis. In: Go VLW, Gardner JD, Brooks FP, Lebenthal E, DiMagno EP, Scheele GA (eds) The exocrine pancreas: Biology, pathophysiology, and diseases. New York: Raven, 1986;465–474.

    Google Scholar 

  3. Warren JS, Ward PA, Johnson KJ. Oxygen radicals as mediators of inflammation. In: Henson PM, Murphy RC (eds) Mediators of the inflammatory process. Amsterdam: Elsevier, 1989; 159–176.

    Google Scholar 

  4. Brigham KL. Mediators of the inflammatory process: Prostanoids. In: Henson PM, Murphy RC (eds) Mediators of the inflammatory process. Amsterdam: Elsevier, 1989;1–14.

    Google Scholar 

  5. Henderson WR. Products of 12- and 15-lipoxygenase. In: Henson PM, Murphy RC (eds) Mediators of the inflammatory process. Amsterdam: Elsevier, 1989;45–76.

    Google Scholar 

  6. Vargaftig BB, Pretolani M, Coeffier E, Chignard M. Platelet-activating factor: Biology, receptors, and antagonists. In: Henson PM, Murphy RC (eds) Mediators of the inflammatory process. Amsterdam: Elsevier, 1989;113–146.

    Google Scholar 

  7. Shaw RJ, Clark RAF. Interleukins and their interactions in inflammation. In: Henson PM, Murphy RC (eds) Mediators of the inflammatory process. Amsterdam: Elsevier, 1989;245–268.

    Google Scholar 

  8. Singer MV, Gyr K, Sarles H. Revised classification of pancreatitis. Report of the second international symposium on the classification of pancreatitis in Marseille, France, March 28–30, 1984. Gastroenterology 1985;89:683–690.

    PubMed  CAS  Google Scholar 

  9. Schmidt JA, Oliver CN, Lepe-Zuniga JL, et al. Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis. J Clin Invest 1984;73:1462–1472.

    PubMed  CAS  Google Scholar 

  10. Canalis E. Interleukin-1 has independent effects on deoxyribonucleic acid and collagen synthesis in cultures of rat calvariae. Endocrinology 1986;118:74–81.

    PubMed  CAS  Google Scholar 

  11. Matsushima K, Bano M, Kidwell WR, Oppenheim JJ. Interleukin 1 increases collagen type IV production by murine mammary epithelial cells. J Immunol 1985;134:904–909.

    PubMed  CAS  Google Scholar 

  12. Browder IW, Sherwood E, Williams D et al. Protective effect of glucagon-enhanced macrophage function in experimental pancreatitis. Am J Surgery 1987;153:25–33.

    Article  CAS  Google Scholar 

  13. Robert A, Zhang W, Lancaster C, Olafsson AS. Effect of interleukin-1 (IL-1), prednisolone, and idomethacin on caerulein-induced acute pancreatitis in rats. Gastroenterology 1991;100:A297.

    Google Scholar 

  14. Leser HG, Gross V, Scheibenbogen C, et al. Elevation of serum interleukin-6 concentration precedes acute phase response and reflects severity in acute pancreatitis. Gastroenterology 1991;101:782–785.

    PubMed  CAS  Google Scholar 

  15. Yamagata S, Ishii K, Tatebe T. Clinical diagnostic criteria of chronic pancreatitis (in Japanese). Jpn J Gastroenterol 1983; 80:1863–1866.

    Google Scholar 

  16. March CJ, Mosley B, Larsen A, et al. Cloning, sequence, and expression of two distinct human interleukin-1 complementary DNAs. Nature 1985;315:641–647.

    Article  PubMed  CAS  Google Scholar 

  17. Anastassakos C, Alexander GJM, Wolstencroft RA, et al. Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology 1988;94:999–1005.

    PubMed  CAS  Google Scholar 

  18. Dinarello CA, Marnoy SO, Rosenwasser LJ. Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte-activating factor/interleukin 1. J Immunol 1983;130:890–895.

    PubMed  CAS  Google Scholar 

  19. Chang J, Gilman SC, Lewis AJ. Interleukin 1 activates phospholipase A2 in rabbit chondrocytes: A possible signal for IL 1 action. J Immunol 1986;136:1283–1287.

    PubMed  CAS  Google Scholar 

  20. Manabe T, Steer ML. Protective effects of PGE2 on diet-induced acute pancreatitis in mice. Gastroenterology 1980;78:777–781.

    PubMed  CAS  Google Scholar 

  21. Robert A, Lum JT, Lancaster C, et al. Prevention by prostaglandins of caerulein-induced pancreatitis in rats. Lab Invest 1989;60:677–691.

    PubMed  CAS  Google Scholar 

  22. Bedossa P, Bacci J, Lemaigre G, Martin E. Lymphocyte subsets and HLA-DR expression in normal pancreas and chronic pancreatitis. Pancreas 1990;5:415–420.

    Article  PubMed  CAS  Google Scholar 

  23. Deviere J, Content J, Denys C, et al. High interleukin-6 serum levels and increased production by leukocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokine production. Clin Exp Immunol 1989;77:221–225.

    PubMed  CAS  Google Scholar 

  24. McClain CJ, Cohen DA, Dinarello CA, et al. Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. Life Sci 1986; 39:1479–1485.

    Article  PubMed  CAS  Google Scholar 

  25. Sheron N, Bird GLA, Goka AKJ, et al. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin Exp Immunol 1991;84:449–453.

    PubMed  CAS  Google Scholar 

  26. Bird GLA, Sheron N, Goka AKJ, et al. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990;112:917–920.

    PubMed  CAS  Google Scholar 

  27. Cavallo MG, Pozzilli P, Bird C, et al. Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin Exp Immunol 1991;86:256–259.

    PubMed  CAS  Google Scholar 

  28. Mooradian AD, Reed RL, Meredith KE, Scuderi P. Serum levels of tumor necrosis factor and IL-1α and IL-1β in diabetic patients. Diabetes Care 1991;14:63–65.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bamba, T., Yoshioka, U., Inoue, H. et al. Serum levels of interleukin-1β and interleukin-6 in patients with chronic pancreatitis. J Gastroenterol 29, 314–319 (1994). https://doi.org/10.1007/BF02358371

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02358371

Key words

Navigation